IQVIA Holdings Inc. (IQV) Stock Investment Calculator & Historical Return Analysis
IQVIA Holdings Inc. is a global leader in health information technology, advanced analytics, and clinical research services. Formed through the merger of Quintiles and IMS Health, it combines data-driven insights with clinical research excellence to provide integrated healthcare services, serving a broad range of clients within the life sciences industry. Investors often view IQVIA Holdings Inc. as a key player in the market, analyzing its long-term potential through various revenue models, brand recognition, and consistent presence in its industry.
This IQVIA Holdings Inc. stock investment calculator allows you to explore how a hypothetical investment in IQV might have performed over time. By adjusting the investment amount and time period, you can visualize potential growth, compare outcomes across different market cycles, and better understand the impact of long-term investing.
What if you invested $1000 in IQV on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Understanding IQVIA Holdings Inc.'s Historical Performance
IQVIA Holdings Inc.'s stock performance has historically reflected both broader market trends and company-specific milestones. Like many growth-oriented stocks, IQV has experienced periods of growth driven by innovation and market demand.
When analyzing IQVIA Holdings Inc.'s historical returns, it's important to consider:
- Market cycles: Strong bull markets often amplify returns, while recessions can temporarily suppress performance.
- Business model evolution: Changes in revenue strategies and product lines can significantly impact stability.
- Long-term trends: Over extended periods, compounding can play a larger role than short-term price fluctuations.
This calculator helps you see how these factors might have affected an investment depending on when you entered the market.
Historical Annual Returns
Over the past 14 years, IQVIA Holdings Inc. has delivered an annualized return (CAGR) of +13.6%. Its strongest year was 2021 at +59.8%, and its weakest was 2022 at -25.1%. Overall, the stock finished in the green 12 times out of 14 years.
Annualized
+13.6%
Win Rate
86%
12W - 2L
Best
+59.8%
2021
Worst
-25.1%
2022
Performance Consistency
IQVIA Holdings Inc. Annual Returns by Year
| Year | Annual Return | Start Price | End Price |
|---|---|---|---|
| 2013 | +10.05% | $42.11 | $46.34 |
| 2014 | +28.54% | $45.80 | $58.87 |
| 2015 | +16.16% | $59.11 | $68.66 |
| 2016 | +13.44% | $67.04 | $76.05 |
| 2017 | +27.26% | $76.93 | $97.90 |
| 2018 | +16.45% | $99.76 | $116.17 |
| 2019 | +35.17% | $114.31 | $154.51 |
| 2020 | +14.55% | $156.41 | $179.17 |
| 2021 | +59.76% | $176.60 | $282.14 |
| 2022 | -25.11% | $273.58 | $204.89 |
| 2023 | +13.50% | $203.86 | $231.38 |
| 2024 | -14.71% | $230.39 | $196.51 |
| 2025 | +15.52% | $195.12 | $225.41 |
| 2026 | +4.71% | $225.37 | $235.99 |
Historical annual returns for IQVIA Holdings Inc.. Each year shows the change from that year's first trading day to its last, using split- and dividend-adjusted closing prices. The current year is partial (year-to-date).
Why Use a "What If" Stock Calculator?
Many investors wonder questions such as:
- What if I had invested 5 years ago?
- How does timing affect long-term returns?
- What role does compounding play in stock investments?
A what-if investment calculator answers these questions by turning historical data into practical insights. Rather than focusing on daily price movements, it encourages a long-term perspective, which is especially useful for retirement planning, portfolio comparisons, and financial education.
Key Innovations
- ✓Development of 'IQVIA Connected Intelligence,' integrating high-quality health data, healthcare-grade AI, advanced analytics, and technology infrastructure to power insights.
- ✓Integration of advanced data analytics and automation into core operational workflows.
- ✓Strategic R&D investment driving next-generation solution design and market differentiation.
- ✓Proprietary technology architecture developed by IQVIA Holdings Inc. to optimize operational performance.
- ✓The strategic merger of IMS Health (specializing in pharmaceutical sales data) and Quintiles (a leader in clinical trials) to create a unique integrated healthcare service provider.
- ✓Expansion of digital transformation initiatives across product engineering and customer delivery.
- ✓A diverse service portfolio that includes innovative approaches to clinical development, real-world evidence generation, and commercialization strategies.
Business Segments
- Technology & Analytics SolutionsOffers health information technology solutions, analytics consulting, and real-world solutions leveraging high-quality health data and AI.
- Research & Development SolutionsProvides full-service contract research organization (CRO) services, managing all phases of clinical trials from early-stage to post-market studies.
- Contract Sales & Medical SolutionsDelivers contract sales services, patient engagement solutions, and commercialization strategies for pharmaceutical and healthcare products.
How to Interpret the Results
The results shown are based on historical performance and are meant for educational and informational purposes only. They do not account for future market conditions, taxes, transaction fees, or individual investment strategies. Past performance does not guarantee future results, but historical analysis can show how an investment behaved across different market cycles.
For best use:
- Compare multiple time ranges to see how outcomes differ
- Use consistent assumptions across different stocks
- Combine this tool with fundamental research and diversification principles